Page last updated: 2024-11-01

ondansetron and Pemphigoid, Benign Mucous Membrane

ondansetron has been researched along with Pemphigoid, Benign Mucous Membrane in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Pemphigoid, Benign Mucous Membrane: A chronic blistering disease with predilection for mucous membranes and less frequently the skin, and with a tendency to scarring. It is sometimes called ocular pemphigoid because of conjunctival mucous membrane involvement.

Research Excerpts

ExcerptRelevanceReference
"Ocular cicatricial pemphigoid (OCP) is a relatively rare autoimmune disease affecting elderly patients and causing severe symptoms that may culminate in blindness."1.40Low-dose pulsed intravenous cyclophosphamide for severe ocular cicatricial pemphigoid in elderly patients. ( Friedman, J; Kleinmann, G; Marcovich, AL; Schattner, A, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Friedman, J1
Marcovich, AL1
Kleinmann, G1
Schattner, A1

Other Studies

1 other study available for ondansetron and Pemphigoid, Benign Mucous Membrane

ArticleYear
Low-dose pulsed intravenous cyclophosphamide for severe ocular cicatricial pemphigoid in elderly patients.
    Cornea, 2014, Volume: 33, Issue:10

    Topics: Aged; Aged, 80 and over; Antiemetics; Cyclophosphamide; Female; Follow-Up Studies; Humans; Immunosup

2014